Anti-Lamin B1 Antibody, clone 6K22, ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Immunogen: His-tagged recombinant fragment corresponding to 137 amino acids from the C-terminal region of human Lamin B1.
• Application: Anti-Lamin B1, clone 6K22 ZooMAb, Cat. No. ZRB1143, is a recombinant rabbit monoclonal antibody that specifically targets Lamin B1 and has been tested for use in Immunocytochemisry, Immunohistochemistry (Paraffin), and Western Blotting.
• Target description: Lamin B1 (UniProt: P20700) is encoded by the LMNB1 (also known as LMN2, LNMB) gene (Gene ID: 4001) in human. The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family proteins make up the matrix and are highly conserved. They are components of the nuclear lamina that provides a framework for the nuclear envelope. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Two types of lamins, A and B, exist in vertebrates. Type B lamins, B1 and B2, are present in all types of cells. Type A lamins are expressed only following gastrulation. Lamin A and C are the most common A-type lamins, they are both encoded by the LMNA gene and produced by alternative splicing. Lamin B1 is a homodimeric protein that is synthesized with a short propeptide (aa 584-586), which is removed in the mature form. The nuclear localization signal of Lamin B1 is localized to amino acids 415-420. Mutations in LMNB1 gene are reported to cause demyelinating Leukodystrophy that leads early autonomic abnormalities, pyramidal and cerebellar dysfunction and later symmetric demyelination of the CNS. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose. Normal appearance is a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 300 μg/mL after reconstitution at 25 μL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.